{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T03:28:52Z","timestamp":1769311732710,"version":"3.49.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T00:00:00Z","timestamp":1563926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T00:00:00Z","timestamp":1563926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Grant-in-Aid for Encouragement of Young Scientists","award":["24791237"],"award-info":[{"award-number":["24791237"]}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["S0801035"],"award-info":[{"award-number":["S0801035"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00213-019-05337-6","type":"journal-article","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T16:02:55Z","timestamp":1563984175000},"page":"3655-3665","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Bupropion increases activation in nucleus accumbens during anticipation of monetary reward"],"prefix":"10.1007","volume":"236","author":[{"given":"Yumiko","family":"Ikeda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Funayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amane","family":"Tateno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhisa","family":"Fukayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiro","family":"Okubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,24]]},"reference":[{"key":"5337_CR1","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1523\/JNEUROSCI.5826-11.2012","volume":"32","author":"B Abler","year":"2012","unstructured":"Abler B, Gr\u00f6n G, Hartmann A, Metzger C, Walter M (2012) Modulation of frontostriatal interaction aligns with reduced primary reward processing under serotonergic drugs. J Neurosci 32:1329\u20131335. \nhttps:\/\/doi.org\/10.1523\/JNEUROSCI.5826-11.2012","journal-title":"J Neurosci"},{"key":"5337_CR2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1037\/1064-1297.16.2.113","volume":"16","author":"A Acheson","year":"2008","unstructured":"Acheson A, de Wit H (2008) Bupropion improves attention but does not affect impulsive behavior in healthy young adults. Exp Clin Psychopharmacol 16:113\u2013123. \nhttps:\/\/doi.org\/10.1037\/1064-1297.16.2.113","journal-title":"Exp Clin Psychopharmacol"},{"key":"5337_CR3","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1176\/appi.ajp.2016.16010111","volume":"174","author":"R Admon","year":"2017","unstructured":"Admon R, Kaiser RH, Dillon DG, Beltzer M, Goer F, Olson DP, Vitaliano G, Pizzagalli DA (2017) Dopaminergic enhancement of striatal response to reward in major depression. Am J Psychiatry 174:378\u2013386. \nhttps:\/\/doi.org\/10.1176\/appi.ajp.2016.16010111","journal-title":"Am J Psychiatry"},{"key":"5337_CR4","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1007\/s00213-018-4955-z","volume":"235","author":"Y Asari","year":"2018","unstructured":"Asari Y, Ikeda Y, Tateno A, Okubo Y, Iijima T, Suzuki H (2018) Acute tramadol enhances brain activity associated with reward anticipation in the nucleus accumbens. Psychopharmacology 235:2631\u20132642. \nhttps:\/\/doi.org\/10.1007\/s00213-018-4955-z","journal-title":"Psychopharmacology"},{"key":"5337_CR5","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/bcp.12116","volume":"77","author":"HJ Aubin","year":"2014","unstructured":"Aubin HJ, Luquiens A, Berlin I (2014) Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice. Br J Clin Pharmacol 77:324\u2013336. \nhttps:\/\/doi.org\/10.1111\/bcp.12116","journal-title":"Br J Clin Pharmacol"},{"key":"5337_CR6","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/eat.22204","volume":"47","author":"IM Balodis","year":"2014","unstructured":"Balodis IM, Grilo CM, Kober H, Worhunsky PD, White MA, Stevens MC, Pearlson GD, Potenza MN (2014) A pilot study linking reduced fronto-striatal recruitment during reward processing to persistent bingeing following treatment for binge-eating disorder. Int J Eat Disord 47:376\u2013384. \nhttps:\/\/doi.org\/10.1002\/eat.22204","journal-title":"Int J Eat Disord"},{"key":"5337_CR7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00213-016-4448-x","volume":"234","author":"ST Barrett","year":"2017","unstructured":"Barrett ST, Geary TN, Steiner AN, Bevins RA (2017) Sex differences and the role of dopamine receptors in the reward-enhancing effects of nicotine and bupropion. Psychopharmacology 234:187\u2013198. \nhttps:\/\/doi.org\/10.1007\/s00213-016-4448-x","journal-title":"Psychopharmacology"},{"key":"5337_CR8","volume-title":"Manual for the Beck Depression Inventory","author":"AT Beck","year":"1996","unstructured":"Beck AT, Steer RA, Brown GK (1996) Manual for the Beck Depression Inventory, 2nd edn. Pearson, Texas","edition":"2"},{"key":"5337_CR9","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1093\/ijnp\/pyx056","volume":"20","author":"P Belujon","year":"2017","unstructured":"Belujon P, Grace AA (2017) Dopamine system dysregulation in major depressive disorders. Int J Neuropsychopharmacol 20:1036\u20131046. \nhttps:\/\/doi.org\/10.1093\/ijnp\/pyx056","journal-title":"Int J Neuropsychopharmacol"},{"key":"5337_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/FPC.0b013e32835d9ab0","volume":"23","author":"NL Benowitz","year":"2013","unstructured":"Benowitz NL, Zhu AZ, Tyndale RF, Dempsey D, Jacob P 3rd (2013) Influence of CYP2B6 genetic variants on plasma and urine concentrations of bupropion and metabolites at steady state. Pharmacogenet Genomics 23:135\u2013141. \nhttps:\/\/doi.org\/10.1097\/FPC.0b013e32835d9ab0","journal-title":"Pharmacogenet Genomics"},{"key":"5337_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2014.04.004","volume":"84","author":"SK Billes","year":"2014","unstructured":"Billes SK, Sinnayah P, Cowley MA (2014) Naltrexone\/bupropion for obesity: an investigational combination pharmacotherapy for weight loss. Pharmacol Res 84:1\u201311. \nhttps:\/\/doi.org\/10.1016\/j.phrs.2014.04.004","journal-title":"Pharmacol Res"},{"issue":"1-2","key":"5337_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0014-2999(84)90386-8","volume":"104","author":"Serge Bischoff","year":"1984","unstructured":"Bischoff S, Bittiger H, Krauss J, Vassout A, Waldmeier P (1984) Affinity changes of rat striatal dopamine receptors in vivo after acute bupropion treatment. Eur J Pharmacol 104:173\u2013176. \nhttps:\/\/doi.org\/10.1016\/0014-2999(84)90386-8","journal-title":"European Journal of Pharmacology"},{"key":"5337_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.2044-8341.1974.tb02285.x","volume":"47","author":"A Bond","year":"1974","unstructured":"Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47:211\u2013218. \nhttps:\/\/doi.org\/10.1111\/j.2044-8341.1974.tb02285.x","journal-title":"Br J Med Psychol"},{"issue":"10031","key":"5337_CR14","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/S0140-6736(16)00271-3","volume":"387","author":"George A Bray","year":"2016","unstructured":"Bray GA, Fr\u00fchbeck G, Ryan DH, Wilding JP (2016) Management of obesity. Lancet 387:1947\u20131956. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(16)00271-3","journal-title":"The Lancet"},{"key":"5337_CR15","doi-asserted-by":"publisher","first-page":"pyu011","DOI":"10.1093\/ijnp\/pyu011","volume":"18","author":"AW Bruijnzeel","year":"2014","unstructured":"Bruijnzeel AW, Alexander JC, Perez PD, Bauzo-Rodriguez R, Hall G, Klausner R, Guerra V, Zeng H, Igari M, Febo M (2014) Acute nicotine administration increases BOLD fMRI signal in brain regions involved in reward signaling and compulsive drug intake in rats. Int J Neuropsychopharmacol 18:pyu011. \nhttps:\/\/doi.org\/10.1093\/ijnp\/pyu011","journal-title":"Int J Neuropsychopharmacol"},{"key":"5337_CR16","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/npp.2011.299","volume":"37","author":"DH Brunzell","year":"2012","unstructured":"Brunzell DH, McIntosh JM (2012) Alpha7 nicotinic acetylcholine receptors modulate motivation to self-administer nicotine: implications for smoking and schizophrenia. Neuropsychopharmacology 37:1134\u20131143. \nhttps:\/\/doi.org\/10.1038\/npp.2011.299","journal-title":"Neuropsychopharmacology"},{"key":"5337_CR17","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nn.2510","volume":"13","author":"JW Buckholtz","year":"2010","unstructured":"Buckholtz JW, Treadway MT, Cowan RL, Woodward ND, Benning SD, Li R, Ansari MS, Baldwin RM, Schwartzman AN, Shelby ES, Smith CE, Cole D, Kessler RM, Zald DH (2010) Mesolimbic dopamine reward system hypersensitivity in individuals with psychopathic traits. Nat Neurosci 13:419\u2013421. \nhttps:\/\/doi.org\/10.1038\/nn.2510","journal-title":"Nat Neurosci"},{"key":"5337_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/BF01276563","volume":"102","author":"SC Cheetham","year":"1995","unstructured":"Cheetham SC, Kettle CJ, Martin KF, Heal DJ (1995) D1 receptor binding in rat striatum: modification by various D1 and D2 antagonists, but not by sibutramine hydrochloride, antidepressants or treatments which enhance central dopaminergic function. J Neural Transm Gen Sect 102:35\u201346. \nhttps:\/\/doi.org\/10.1007\/BF01276563","journal-title":"J Neural Transm Gen Sect"},{"key":"5337_CR19","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s00228-012-1418-z","volume":"69","author":"H Chevassus","year":"2013","unstructured":"Chevassus H, Farret A, Gagnol JP, Pon\u00e7on CA, Costa F, Roux C, Galtier F, Petit P (2013) Psychological and physiological effects of bupropion compared to methylphenidate after prolonged administration in healthy volunteers (NCT00285155). Eur J Clin Pharmacol 69:779\u2013787. \nhttps:\/\/doi.org\/10.1007\/s00228-012-1418-z","journal-title":"Eur J Clin Pharmacol"},{"key":"5337_CR20","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1097\/00004583-199610000-00018","volume":"35","author":"CK Conners","year":"1996","unstructured":"Conners CK, Casat CD, Gualtieri CT, Weller E, Reader M, Reiss A, Weller RA, Khayrallah M, Ascher J (1996) Bupropion hydrochloride in attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry 35:1314\u20131321. \nhttps:\/\/doi.org\/10.1097\/00004583-199610000-00018","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"5337_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1037\/abn0000016","volume":"124","author":"JW Cook","year":"2015","unstructured":"Cook JW, Piper ME, Leventhal AM, Schlam TR, Fiore MC, Baker TB (2015) Anhedonia as a component of the tobacco withdrawal syndrome. J Abnorm Psychol 124:215\u2013225. \nhttps:\/\/doi.org\/10.1037\/abn0000016","journal-title":"J Abnorm Psychol"},{"issue":"3","key":"5337_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00213-003-1445-7","volume":"168","author":"John F. Cryan","year":"2003","unstructured":"Cryan JF, Bruijnzeel AW, Skjei KL, Markou A (2003) Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat. Psychopharmacology 168: 347\u2013358. \nhttps:\/\/doi.org\/10.1007\/s00213-003-1445-7","journal-title":"Psychopharmacology"},{"key":"5337_CR23","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1124\/mol.104.001313","volume":"66","author":"MI Damaj","year":"2004","unstructured":"Damaj MI, Carroll FI, Eaton JB, Navarro HA, Blough BE, Mirza S, Lukas RJ, Martin BR (2004) Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors. Mol Pharmacol 66:675\u2013682. \nhttps:\/\/doi.org\/10.1124\/mol.104.001313","journal-title":"Mol Pharmacol"},{"key":"5337_CR24","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.biopsych.2005.04.028","volume":"58","author":"SP David","year":"2005","unstructured":"David SP, Munaf\u00f2 MR, Johansen-Berg H, Smith SM, Rogers RD, Matthews PM, Walton RT (2005) Ventral striatum\/nucleus accumbens activation to smoking-related pictorial cues in smokers and nonsmokers: a functional magnetic resonance imaging study. Biol Psychiatry 58:488\u2013494. \nhttps:\/\/doi.org\/10.1016\/j.biopsych.2005.04.028","journal-title":"Biol Psychiatry"},{"key":"5337_CR25","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1017\/S003329171600088X","volume":"46","author":"Z Dean","year":"2016","unstructured":"Dean Z, Horndasch S, Giannopoulos P, McCabe C (2016) Enhanced neural response to anticipation, effort and consummation of reward and aversion during bupropion treatment. Psychol Med 46:2263\u20132274. \nhttps:\/\/doi.org\/10.1017\/S003329171600088X","journal-title":"Psychol Med"},{"key":"5337_CR26","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2165\/00003495-200868050-00011","volume":"68","author":"S Dhillon","year":"2008","unstructured":"Dhillon S, Yang LP, Curran MP (2008) Bupropion: a review of its use in the management of major depressive disorder. Drugs 68:653\u2013689. \nhttps:\/\/doi.org\/10.2165\/00003495-200868050-00011","journal-title":"Drugs"},{"key":"5337_CR27","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1527-3458.2006.00178.x","volume":"12","author":"LP Dwoskin","year":"2006","unstructured":"Dwoskin LP, Rauhut AS, King-Pospisil KA, Bardo MT (2006) Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent. CNS Drug Rev 12:178\u2013207. \nhttps:\/\/doi.org\/10.1111\/j.1527-3458.2006.00178.x","journal-title":"CNS Drug Rev"},{"key":"5337_CR28","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.neuroimage.2009.11.077","volume":"50","author":"A Egerton","year":"2010","unstructured":"Egerton A, Shotbolt JP, Stokes PR, Hirani E, Ahmad R, Lappin JM, Reeves SJ, Mehta MA, Howes OD, Grasby PM (2010) Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: an [11C]raclopride PET study. Neuroimage 50:260\u2013266. \nhttps:\/\/doi.org\/10.1016\/j.neuroimage.2009.11.077","journal-title":"Neuroimage"},{"key":"5337_CR29","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.metabol.2016.02.002","volume":"65","author":"OM Farr","year":"2016","unstructured":"Farr OM, Li CS, Mantzoros CS (2016) Central nervous system regulation of eating: insights from human brain imaging. Metabolism 65:699\u2013713. \nhttps:\/\/doi.org\/10.1016\/j.metabol.2016.02.002","journal-title":"Metabolism"},{"key":"5337_CR30","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang AG, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175\u2013191. \nhttps:\/\/doi.org\/10.3758\/BF03193146","journal-title":"Behav Res Methods"},{"key":"5337_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1517\/eoed.9.1.39.32951","volume":"9","author":"J Foulds","year":"2004","unstructured":"Foulds J, Burke M, Steinberg M, Williams JM, Ziedonis DM (2004) Advances in pharmacotherapy for tobacco dependence. Expert Opin Emerg Drugs 9:39\u201353. \nhttps:\/\/doi.org\/10.1517\/eoed.9.1.39.32951","journal-title":"Expert Opin Emerg Drugs"},{"key":"5337_CR32","first-page":"88","volume":"288","author":"JD Fryer","year":"1999","unstructured":"Fryer JD, Lukas RJ (1999) Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine. J Pharmacol Exp Ther 288:88\u201392","journal-title":"J Pharmacol Exp Ther"},{"key":"5337_CR33","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1007\/s00213-014-3499-0","volume":"231","author":"T Funayama","year":"2014","unstructured":"Funayama T, Ikeda Y, Tateno A, Takahashi H, Okubo Y, Fukayama H, Suzuki H (2014) Modafinil augments brain activation associated with reward anticipation in the nucleus accumbens. Psychopharmacology 231:3217\u20133228. \nhttps:\/\/doi.org\/10.1007\/s00213-014-3499-0","journal-title":"Psychopharmacology"},{"key":"5337_CR34","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.tips.2003.11.003","volume":"25","author":"TP George","year":"2004","unstructured":"George TP, O\u2019Malley SS (2004) Current pharmacological treatments for nicotine dependence. Trends Pharmacol Sci 25:42\u201348. \nhttps:\/\/doi.org\/10.1016\/j.tips.2003.11.003","journal-title":"Trends Pharmacol Sci"},{"key":"5337_CR35","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/01.jcp.0000084023.22282.03","volume":"23","author":"G Gobbi","year":"2003","unstructured":"Gobbi G, Slater S, Boucher N, Debonnel G, Blier P (2003) Neurochemical and psychotropic effects of bupropion in healthy male subjects. J Clin Psychopharmacol 23:233\u2013239. \nhttps:\/\/doi.org\/10.1097\/01.jcp.0000084023.22282.03","journal-title":"J Clin Psychopharmacol"},{"key":"5337_CR36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/WNR.0000000000000487","volume":"27","author":"H Graf","year":"2016","unstructured":"Graf H, Metzger CD, Walter M, Abler B (2016) Serotonergic antidepressants decrease hedonic signals but leave learning signals in the nucleus accumbens unaffected. Neuroreport 27:18\u201322. \nhttps:\/\/doi.org\/10.1097\/WNR.0000000000000487","journal-title":"Neuroreport"},{"key":"5337_CR37","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.neuropharm.2009.09.009","volume":"58","author":"BJ Hall","year":"2010","unstructured":"Hall BJ, Pearson LS, Buccafusco JJ (2010) Effect of administration of the nicotinic acetylcholine receptor antagonist BTMPS, during nicotine self-administration, on lever responding induced by context long after withdrawal. Neuropharmacology 58:429\u2013435. \nhttps:\/\/doi.org\/10.1016\/j.neuropharm.2009.09.009","journal-title":"Neuropharmacology"},{"key":"5337_CR38","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","volume":"32","author":"M Hamilton","year":"1959","unstructured":"Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32:50\u201355. \nhttps:\/\/doi.org\/10.1111\/j.2044-8341.1959.tb00467.x","journal-title":"Br J Med Psychol"},{"key":"5337_CR39","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56\u201362. \nhttps:\/\/doi.org\/10.1136\/jnnp.23.1.56","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5337_CR40","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1365-2125.1982.tb02038.x","volume":"14","author":"MJ Hamilton","year":"1982","unstructured":"Hamilton MJ, Bush M, Smith P, Peck AW (1982) The effects of bupropion, a new antidepressant drug, and diazepam, and their interaction in man. Br J Clin Pharmacol 14:791\u2013797. \nhttps:\/\/doi.org\/10.1111\/j.1365-2125.1982.tb02038.x","journal-title":"Br J Clin Pharmacol"},{"key":"5337_CR41","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.psychres.2007.04.012","volume":"160","author":"I Herrera-Guzm\u00e1n","year":"2008","unstructured":"Herrera-Guzm\u00e1n I, Gudayol-Ferr\u00e9 E, Lira-Mandujano J, Herrera-Abarca J, Herrera-Guzm\u00e1n D, Montoya-P\u00e9rez K, Guardia-Olmos J (2008) Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder. Psychiatry Res 160:72\u201382. \nhttps:\/\/doi.org\/10.1016\/j.psychres.2007.04.012","journal-title":"Psychiatry Res"},{"key":"5337_CR42","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/ijnp\/pyy081","volume":"22","author":"A H\u00f6flich","year":"2019","unstructured":"H\u00f6flich A, Michenthaler P, Kasper S, Lanzenberger R (2019) Circuit mechanisms of reward, anhedonia, and depression. Int J Neuropsychopharmacol 22:105\u2013118. \nhttps:\/\/doi.org\/10.1093\/ijnp\/pyy081","journal-title":"Int J Neuropsychopharmacol"},{"key":"5337_CR43","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/FTD.0000000000000183","volume":"37","author":"G H\u00f8iseth","year":"2015","unstructured":"H\u00f8iseth G, Haslemo T, Uthus LH, Molden E (2015) Effect of CYP2B6*6 on steady-state serum concentrations of bupropion and hydroxybupropion in psychiatric patients: a study based on therapeutic drug monitoring data. Ther Drug Monit 37:589\u2013593. \nhttps:\/\/doi.org\/10.1097\/FTD.0000000000000183","journal-title":"Ther Drug Monit"},{"key":"5337_CR44","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.vph.2005.08.030","volume":"45","author":"L Jasmin","year":"2006","unstructured":"Jasmin L, Narasaiah M, Tien D (2006) Noradrenaline is necessary for the hedonic properties of addictive drugs. Vasc Pharmacol 45:243\u2013250. \nhttps:\/\/doi.org\/10.1016\/j.vph.2005.08.030","journal-title":"Vasc Pharmacol"},{"key":"5337_CR45","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","volume":"14","author":"MW Johns","year":"1991","unstructured":"Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540\u2013545. \nhttps:\/\/doi.org\/10.1093\/sleep\/14.6.540","journal-title":"Sleep"},{"key":"5337_CR46","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1017\/S1461145713001612","volume":"17","author":"W Kim","year":"2014","unstructured":"Kim W, Tateno A, Arakawa R, Sakayori T, Ikeda Y, Suzuki H, Okubo Y (2014) In vivo activity of modafinil on dopamine transporter measured with positron emission tomography and [18F]FE-PE2I. Int J Neuropsychopharmacol 17:697\u2013703. \nhttps:\/\/doi.org\/10.1017\/S1461145713001612","journal-title":"Int J Neuropsychopharmacol"},{"key":"5337_CR47","doi-asserted-by":"publisher","first-page":"RC159","DOI":"10.1523\/JNEUROSCI.21-16-j0002.2001","volume":"21","author":"B Knutson","year":"2001","unstructured":"Knutson B, Adams CM, Fong GW, Hommer D (2001) Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J Neurosci 21:RC159. \nhttps:\/\/doi.org\/10.1523\/JNEUROSCI.21-16-j0002.2001","journal-title":"J Neurosci"},{"key":"5337_CR48","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.biopsych.2007.07.023","volume":"63","author":"B Knutson","year":"2008","unstructured":"Knutson B, Bhanji JP, Cooney RE, Atlas LY, Gotlib IH (2008) Neural responses to monetary incentives in major depression. Biol Psychiatry 63:686\u2013692. \nhttps:\/\/doi.org\/10.1016\/j.biopsych.2007.07.023","journal-title":"Biol Psychiatry"},{"key":"5337_CR49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.physbeh.2016.04.020","volume":"162","author":"NB Kroemer","year":"2016","unstructured":"Kroemer NB, Small DM (2016) Fuel not fun: reinterpreting attenuated brain responses to reward in obesity. Physiol Behav 162:37\u201345. \nhttps:\/\/doi.org\/10.1016\/j.physbeh.2016.04.020","journal-title":"Physiol Behav"},{"issue":"8","key":"5337_CR50","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/S0006-3223(02)01834-6","volume":"54","author":"Susan M Learned-Coughlin","year":"2003","unstructured":"Learned-Coughlin SM, Bergstr\u00f6m M, Savitcheva I, Ascher J, Schmith VD, L\u00e5ngstrom B (2003) In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography. Biol Psychiatry 54:800\u2013805. \nhttps:\/\/doi.org\/10.1016\/S0006-3223(02)01834-6","journal-title":"Biological Psychiatry"},{"issue":"2","key":"5337_CR51","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0028-3908(01)00160-5","volume":"42","author":"Simon Xi-Ming Li","year":"2002","unstructured":"Li SX, Perry KW, Wong DT (2002) Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats. Neuropharmacology 42:181\u2013190. \nhttps:\/\/doi.org\/10.1016\/S0028-3908(01)00160-5","journal-title":"Neuropharmacology"},{"key":"5337_CR52","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.12659\/MSM.909227","volume":"24","author":"H Ma","year":"2018","unstructured":"Ma H, Zhang W, Yang X, Zhang Y, Wei S, Zhang H, Ma Y, Dang H (2018) Effects of genetic polymorphisms of CYP2B6 on the pharmacokinetics of bupropion and hydroxybupropion in healthy Chinese subjects. Med Sci Monit 24:2158\u20132163. \nhttps:\/\/doi.org\/10.12659\/MSM.909227","journal-title":"Med Sci Monit"},{"key":"5337_CR53","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.bcp.2007.07.034","volume":"74","author":"HD Mansvelder","year":"2007","unstructured":"Mansvelder HD, Fagen ZM, Chang B, Mitchum R, McGehee DS (2007) Bupropion inhibits the cellular effects of nicotine in the ventral tegmental area. Biochem Pharmacol 74:1283\u20131291. \nhttps:\/\/doi.org\/10.1016\/j.bcp.2007.07.034","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"5337_CR54","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/0091-3057(95)00095-E","volume":"51","author":"K.F. Martin","year":"1995","unstructured":"Martin KF, Phillips I, Cheetham SC, Heal DJ (1995) Dopamine D2 receptors: a potential pharmacological target for nomifensine and tranylcypromine but not other antidepressant treatments. Pharmacol Biochem Behav 51:565\u2013569. \nhttps:\/\/doi.org\/10.1016\/0091-3057(95)00095-E","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"5337_CR55","volume-title":"Manual for the Profile of Mood States","author":"DM McNair","year":"1971","unstructured":"McNair DM, Lorr M, Droppleman LF (1971) Manual for the Profile of Mood States. Educational and Industrial Testing Service, California"},{"key":"5337_CR56","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1586\/14737175.6.7.965","volume":"6","author":"ME Mooney","year":"2006","unstructured":"Mooney ME, Sofuoglu M (2006) Bupropion for the treatment of nicotine withdrawal and craving. Expert Rev Neurother 6:965\u2013981. \nhttps:\/\/doi.org\/10.1586\/14737175.6.7.965","journal-title":"Expert Rev Neurother"},{"key":"5337_CR57","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ejphar.2013.07.046","volume":"718","author":"T Mori","year":"2013","unstructured":"Mori T, Shibasaki M, Ogawa Y, Hokazono M, Wang TC, Rahmadi M, Suzuki T (2013) Comparison of the behavioral effects of bupropion and psychostimulants. Eur J Pharmacol 718:370\u2013375. \nhttps:\/\/doi.org\/10.1016\/j.ejphar.2013.07.046","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"5337_CR58","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0028-3932(71)90067-4","volume":"9","author":"R.C. Oldfield","year":"1971","unstructured":"Oldfield RC (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9:97\u2013113. \nhttps:\/\/doi.org\/10.1016\/0028-3932(71)90067-4","journal-title":"Neuropsychologia"},{"key":"5337_CR59","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1002\/hbm.24184","volume":"39","author":"S Oldham","year":"2018","unstructured":"Oldham S, Murawski C, Fornito A, Youssef G, Y\u00fccel M, Lorenzetti V (2018) The anticipation and outcome phases of reward and loss processing: a neuroimaging meta-analysis of the monetary incentive delay task. Hum Brain Mapp 39:3398\u20133418. \nhttps:\/\/doi.org\/10.1002\/hbm.24184","journal-title":"Hum Brain Mapp"},{"key":"5337_CR60","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.biopsych.2011.03.041","volume":"70","author":"L Ossewaarde","year":"2011","unstructured":"Ossewaarde L, Verkes RJ, Hermans EJ, Kooijman SC, Urner M, Tendolkar I, van Wingen GA, Fern\u00e1ndez G (2011) Two-week administration of the combined serotonin-noradrenaline reuptake inhibitor duloxetine augments functioning of mesolimbic incentive processing circuits. Biol Psychiatry 70:568\u2013574. \nhttps:\/\/doi.org\/10.1016\/j.biopsych.2011.03.041","journal-title":"Biol Psychiatry"},{"key":"5337_CR61","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00213-009-1666-5","volume":"207","author":"MI Palmatier","year":"2009","unstructured":"Palmatier MI, Levin ME, Mays KL, Donny EC, Caggiula AR, Sved AF (2009) Bupropion and nicotine enhance responding for nondrug reinforcers via dissociable pharmacological mechanisms in rats. Psychopharmacology 207:381\u2013390. \nhttps:\/\/doi.org\/10.1007\/s00213-009-1666-5","journal-title":"Psychopharmacology"},{"key":"5337_CR62","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/2045125316629071","volume":"6","author":"K Patel","year":"2016","unstructured":"Patel K, Allen S, Haque MN, Angelescu I, Baumeister D, Tracy DK (2016) Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant. Ther Adv Psychopharmacol 6:99\u2013144. \nhttps:\/\/doi.org\/10.1177\/2045125316629071","journal-title":"Ther Adv Psychopharmacol"},{"key":"5337_CR63","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1111\/j.1460-9568.2007.05546.x","volume":"25","author":"NE Paterson","year":"2007","unstructured":"Paterson NE, Balfour DJ, Markou A (2007) Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell. Eur J Neurosci 25:3099\u20133108. \nhttps:\/\/doi.org\/10.1111\/j.1460-9568.2007.05546.x","journal-title":"Eur J Neurosci"},{"key":"5337_CR64","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1176\/appi.ajp.2010.10071024","volume":"168","author":"J Peters","year":"2011","unstructured":"Peters J, Bromberg U, Schneider S, Brassen S, Menz M, Banaschewski T, Conrod PJ, Flor H, Gallinat J, Garavan H, Heinz A, Itterman B, Lathrop M, Martinot JL, Paus T, Poline JB, Robbins TW, Rietschel M, Smolka M, Str\u00f6hle A, Struve M, Loth E, Schumann G, B\u00fcchel C, IMAGEN Consortium (2011) Lower ventral striatal activation during reward anticipation in adolescent smokers. Am J Psychiatry 168:540\u2013549. \nhttps:\/\/doi.org\/10.1176\/appi.ajp.2010.10071024","journal-title":"Am J Psychiatry"},{"key":"5337_CR65","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1176\/appi.ajp.2008.08081201","volume":"166","author":"DA Pizzagalli","year":"2009","unstructured":"Pizzagalli DA, Holmes AJ, Dillon DG, Goetz EL, Birk JL, Bogdan R, Dougherty DD, Iosifescu DV, Rauch SL, Fava M (2009) Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. Am J Psychiatry 166:702\u2013710. \nhttps:\/\/doi.org\/10.1176\/appi.ajp.2008.08081201","journal-title":"Am J Psychiatry"},{"key":"5337_CR66","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.pnpbp.2017.09.008","volume":"81","author":"CN Pujol","year":"2018","unstructured":"Pujol CN, Paasche C, Laprevote V, Trojak B, Vidailhet P, Bacon E, Lalanne L (2018) Cognitive effects of labeled addictolytic medications. Prog Neuro-Psychopharmacol Biol Psychiatry 81:306\u2013332. \nhttps:\/\/doi.org\/10.1016\/j.pnpbp.2017.09.008","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"1-3","key":"5337_CR67","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ejphar.2008.10.037","volume":"601","author":"Shafiqur Rahman","year":"2008","unstructured":"Rahman S, Neugebauer NM, Zhang Z, Crooks PA, Dwoskin LP, Bardo MT (2008) The novel nicotinic receptor antagonist N,N\u2019-dodecane-1,12-diyl-bis-3-picolinium dibromide decreases nicotine-induced dopamine metabolism in rat nucleus accumbens. Eur J Pharmacol 601:103\u2013105. \nhttps:\/\/doi.org\/10.1016\/j.ejphar.2008.10.037","journal-title":"European Journal of Pharmacology"},{"key":"5337_CR68","doi-asserted-by":"publisher","first-page":"pyu017","DOI":"10.1093\/ijnp\/pyu017","volume":"18","author":"PA Randall","year":"2014","unstructured":"Randall PA, Lee CA, Podurgiel SJ, Hart E, Yohn SE, Jones M, Rowland M, L\u00f3pez-Cruz L, Correa M, Salamone JD (2014) Bupropion increases selection of high effort activity in rats tested on a progressive ratio\/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms. Int J Neuropsychopharmacol 18:pyu017. \nhttps:\/\/doi.org\/10.1093\/ijnp\/pyu017","journal-title":"Int J Neuropsychopharmacol"},{"key":"5337_CR69","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.neuropharm.2005.05.004","volume":"49","author":"KS Rau","year":"2005","unstructured":"Rau KS, Birdsall E, Hanson JE, Johnson-Davis KL, Carroll FI, Wilkins DG, Gibb JW, Hanson GR, Fleckenstein AE (2005) Bupropion increases striatal vesicular monoamine transport. Neuropharmacology 49:820\u2013830. \nhttps:\/\/doi.org\/10.1016\/j.neuropharm.2005.05.004","journal-title":"Neuropharmacology"},{"key":"5337_CR70","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1254\/jphs.08168FP","volume":"108","author":"H Sagara","year":"2008","unstructured":"Sagara H, Kitamura Y, Yae T, Shibata K, Suemaru K, Sendo T, Araki H, Gomita Y (2008) Nicotinic acetylcholine \u03b14\u03b22 receptor regulates the motivational effect of intracranial self stimulation behavior in the runway method. J Pharmacol Sci 108:455\u2013461. \nhttps:\/\/doi.org\/10.1254\/jphs.08168FP","journal-title":"J Pharmacol Sci"},{"key":"5337_CR71","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1017\/S1461145712001678","volume":"16","author":"K Saji","year":"2013","unstructured":"Saji K, Ikeda Y, Kim W, Shingai Y, Tateno A, Takahashi H, Okubo Y, Fukayama H, Suzuki H (2013) Acute NK1 receptor antagonist administration affects reward incentive anticipation processing in healthy volunteers. Int J Neuropsychopharmacol 16:1461\u20131471. \nhttps:\/\/doi.org\/10.1017\/S1461145712001678","journal-title":"Int J Neuropsychopharmacol"},{"key":"5337_CR72","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1023\/A:1006986824213","volume":"19","author":"C S\u00e1nchez","year":"1999","unstructured":"S\u00e1nchez C, Hyttel J (1999) Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell Mol Neurobiol 19:467\u2013489. \nhttps:\/\/doi.org\/10.1023\/A:1006986824213","journal-title":"Cell Mol Neurobiol"},{"key":"5337_CR73","doi-asserted-by":"publisher","first-page":"14311","DOI":"10.1523\/JNEUROSCI.2058-08.2008","volume":"28","author":"BH Schott","year":"2008","unstructured":"Schott BH, Minuzzi L, Krebs RM, Elmenhorst D, Lang M, Winz OH, Seidenbecher CI, Coenen HH, Heinze HJ, Zilles K, D\u00fczel E, Bauer A (2008) Mesolimbic functional magnetic resonance imaging activations during reward anticipation correlate with reward-related ventral striatal dopamine release. J Neurosci 28:14311\u201314319. \nhttps:\/\/doi.org\/10.1523\/JNEUROSCI.2058-08.2008","journal-title":"J Neurosci"},{"key":"5337_CR74","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.neubiorev.2013.02.002","volume":"37","author":"G Sescousse","year":"2013","unstructured":"Sescousse G, Cald\u00fa X, Segura B, Dreher JC (2013) Processing of primary and secondary rewards: a quantitative meta-analysis and review of human functional neuroimaging studies. Neurosci Biobehav Rev 37:681\u2013696. \nhttps:\/\/doi.org\/10.1016\/j.neubiorev.2013.02.002","journal-title":"Neurosci Biobehav Rev"},{"key":"5337_CR75","first-page":"321","volume":"295","author":"JE Slemmer","year":"2000","unstructured":"Slemmer JE, Martin BR, Damaj MI (2000) Bupropion is a nicotinic antagonist. J Pharmacol Exp Ther 295:321\u2013327","journal-title":"J Pharmacol Exp Ther"},{"key":"5337_CR76","volume-title":"Manual for the State-Trait Anxiety Inventory, STAI-form Y","author":"CD Spielberger","year":"1983","unstructured":"Spielberger CD (1983) Manual for the State-Trait Anxiety Inventory, STAI-form Y. Consulting Psychologists Press, California"},{"issue":"Suppl.1","key":"5337_CR77","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1016\/j.drugalcdep.2012.01.017","volume":"123","author":"MM Sweitzer","year":"2012","unstructured":"Sweitzer MM, Donny EC, Hariri AR (2012) Imaging genetics and the neurobiological basis of individual differences in vulnerability to addiction. Drug Alcohol Depend 123(Suppl.1):S59\u2013S71. \nhttps:\/\/doi.org\/10.1016\/j.drugalcdep.2012.01.017","journal-title":"Drug Alcohol Depend"},{"key":"5337_CR78","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.pnpbp.2017.07.006","volume":"79","author":"M Takamura","year":"2017","unstructured":"Takamura M, Okamoto Y, Okada G, Toki S, Yamamoto T, Ichikawa N, Mori A, Minagawa H, Takaishi Y, Fujii Y, Kaichi Y, Akiyama Y, Awai K, Yamawaki S (2017) Patients with major depressive disorder exhibit reduced reward size coding in the striatum. Prog Neuro-Psychopharmacol Biol Psychiatry 79:317\u2013323. \nhttps:\/\/doi.org\/10.1016\/j.pnpbp.2017.07.006","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"5337_CR79","volume-title":"Co-planar stereotaxic atlas of the human brain: 3-dimensional proportional system\u2014an approach to cerebral imaging","author":"J Talairach","year":"1988","unstructured":"Talairach J, Tournoux P (1988) Co-planar stereotaxic atlas of the human brain: 3-dimensional proportional system\u2014an approach to cerebral imaging. Thieme Medical Publishers, New York"},{"key":"5337_CR80","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.dcn.2015.10.010","volume":"17","author":"EH Telzer","year":"2016","unstructured":"Telzer EH (2016) Dopaminergic reward sensitivity can promote adolescent health: a new perspective on the mechanism of ventral striatum activation. Dev Cogn Neurosci 17:57\u201367. \nhttps:\/\/doi.org\/10.1016\/j.dcn.2015.10.010","journal-title":"Dev Cogn Neurosci"},{"key":"5337_CR81","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s002130050443","volume":"134","author":"P Terry","year":"1997","unstructured":"Terry P, Katz JL (1997) Dopaminergic mediation of the discriminative stimulus effects of bupropion in rats. Psychopharmacology 134:201\u2013212. \nhttps:\/\/doi.org\/10.1007\/s002130050443","journal-title":"Psychopharmacology"},{"key":"5337_CR82","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00213-012-2703-3","volume":"223","author":"KM Tobey","year":"2012","unstructured":"Tobey KM, Walentiny DM, Wiley JL, Carroll FI, Damaj MI, Azar MR, Koob GF, George O, Harris LS, Vann RE (2012) Effects of the specific \u03b14\u03b22 nAChR antagonist, 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine, on nicotine reward-related behaviors in rats and mice. Psychopharmacology 223:159\u2013168. \nhttps:\/\/doi.org\/10.1007\/s00213-012-2703-3","journal-title":"Psychopharmacology"},{"key":"5337_CR83","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/hbm.23407","volume":"38","author":"J Verdejo-Rom\u00e1n","year":"2017","unstructured":"Verdejo-Rom\u00e1n J, Vilar-L\u00f3pez R, Navas JF, Soriano-Mas C, Verdejo-Garc\u00eda A (2017) Brain reward system\u2019s alterations in response to food and monetary stimuli in overweight and obese individuals. Hum Brain Mapp 38:666\u2013677. \nhttps:\/\/doi.org\/10.1002\/hbm.23407","journal-title":"Hum Brain Mapp"},{"key":"5337_CR84","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/ntr\/ntx002","volume":"19","author":"F Versace","year":"2017","unstructured":"Versace F, Engelmann JM, Deweese MM, Robinson JD, Green CE, Lam CY, Minnix JA, Karam-Hage MA, Wetter DW, Schembre SM, Cinciripini PM (2017) Beyond cue reactivity: non-drug-related motivationally relevant stimuli are necessary to understand reactivity to drug-related cues. Nicotine Tob Res 19:663\u2013669. \nhttps:\/\/doi.org\/10.1093\/ntr\/ntx002","journal-title":"Nicotine Tob Res"},{"key":"5337_CR85","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.cell.2015.07.046","volume":"162","author":"ND Volkow","year":"2015","unstructured":"Volkow ND, Morales M (2015) The brain on drugs: from reward to addiction. Cell 162:712\u2013725. \nhttps:\/\/doi.org\/10.1016\/j.cell.2015.07.046","journal-title":"Cell"},{"key":"5337_CR86","doi-asserted-by":"publisher","first-page":"20170030","DOI":"10.1098\/rstb.2017.0030","volume":"373","author":"AEL Walsh","year":"2018","unstructured":"Walsh AEL, Browning M, Drevets WC, Furey M, Harmer CJ (2018) Dissociable temporal effects of bupropion on behavioural measures of emotional and reward processing in depression. Philos Trans R Soc Lond Ser B Biol Sci 373:20170030. \nhttps:\/\/doi.org\/10.1098\/rstb.2017.0030","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"key":"5337_CR87","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1038\/sj.npp.1301263","volume":"32","author":"D Weinshenker","year":"2007","unstructured":"Weinshenker D, Schroeder JP (2007) There and back again: a tale of norepinephrine and drug addiction. Neuropsychopharmacology 32:1433\u20131451. \nhttps:\/\/doi.org\/10.1038\/sj.npp.1301263","journal-title":"Neuropsychopharmacology"},{"key":"5337_CR88","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/YCO.0000000000000122","volume":"28","author":"AE Whitton","year":"2015","unstructured":"Whitton AE, Treadway MT, Pizzagalli DA (2015) Reward processing dysfunction in major depression, bipolar disorder and schizophrenia. Curr Opin Psychiatry 28:7\u201312. \nhttps:\/\/doi.org\/10.1097\/YCO.0000000000000122","journal-title":"Curr Opin Psychiatry"},{"issue":"4","key":"5337_CR89","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s11065-018-9385-5","volume":"28","author":"Robin Paul Wilson","year":"2018","unstructured":"Wilson RP, Colizzi M, Bossong MG, Allen P, Kempton M; MTAC, Bhattacharyya S (2018) The neural substrate of reward anticipation in health: a meta-analysis of fMRI findings in the monetary incentive delay task. Neuropsychol Rev 28:496\u2013506. \nhttps:\/\/doi.org\/10.1007\/s11065-018-9385-5","journal-title":"Neuropsychology Review"},{"key":"5337_CR90","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2174\/1570159X13666150121225659","volume":"13","author":"M Zaniewska","year":"2015","unstructured":"Zaniewska M, Filip M, Przegalinski E (2015) The involvement of norepinephrine in behaviors related to psychostimulant addiction. Curr Neuropharmacol 13:407\u2013418. \nhttps:\/\/doi.org\/10.2174\/1570159X13666150121225659","journal-title":"Curr Neuropharmacol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-019-05337-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-019-05337-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-019-05337-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T23:08:14Z","timestamp":1595459294000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-019-05337-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,24]]},"references-count":90,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5337"],"URL":"https:\/\/doi.org\/10.1007\/s00213-019-05337-6","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,24]]},"assertion":[{"value":"22 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants gave written informed consent, and the study was approved by the ethics committee of Nippon Medical School (approval number 223035).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors are entirely responsible for the scientific content of this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}